Comparison of TP53 mutation analysis findings for tar pitch dermatopathy and ionizing radiation-related skin cancer

被引:0
|
作者
Ishino, Keiko [1 ]
Yamada, Hidetaka [1 ]
Kahyo, Tomoaki [1 ]
Hino, Ryosuke [2 ]
Nakamura, Motonobu [2 ]
Shimajiri, Shohei [3 ]
Hisaoka, Masanori [4 ]
Kasami, Masako [5 ]
Tokura, Yoshiki [6 ]
Sugimura, Haruhiko [1 ]
机构
[1] Hamamatsu Univ, Sch Med, Dept Tumor Pathol, 1-20-1 Handayama,Higashi Ku, Hamamatsu, Shizuoka 4313192, Japan
[2] Univ Occupat & Environm Hlth, Dept Dermatol, Kitakyushu, Fukuoka, Japan
[3] Univ Occupat & Environm Hlth, Dept Surg Pathol, Kitakyushu, Fukuoka, Japan
[4] Univ Occupat & Environm Hlth, Sch Med, Dept Pathol & Oncol, Kitakyushu, Fukuoka, Japan
[5] Iwata City Hosp, Div Diagnost Pathol, Iwata, Shizuoka, Japan
[6] Chutoen Gen Med Ctr, Allerg Dis Res Ctr, Kakegawa, Shizuoka, Japan
关键词
TP53; mutation spectrum; Tar-pitch dermatopathy; skin cancer; radiation; environmental carcinogenesis; P53; MUTATION;
D O I
暂无
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Background: Tar has been well known as a carcinogen ever since Yamagiwa artificially induced carcinogenesis for the first time by painting a rabbit ear with tar 100 years ago. While humans can be exposed to tar under numerous circumstances, few molecular pathological analyses of skin lesions caused by "tar pitch dermatopathy" have been performed because tar pitch dermatopathy itself is currently rare. Methods: A mutation analysis of TP53 was conducted using long-term stored formalin-fixed, paraffin-embedded tissue specimens of tar pitch dermatopathy in 4 subjects; a similar analysis of radiation-induced skin cancer in 2 subjects was also performed for comparison. Multiple sites were analyzed. Results: Among the specimens from the 4 subjects with tar pitch dermatopathy, the mutations c.625A>T and c.715A>G were each found in 1 of the lesion specimens, whereas the wild type for TP53 was seen in all the non-tumorous skin samples from these cases. The additional mutation c.503A>C was also detected in a different portion of the specimen from the case in which c.715A>G had been detected. In contrast, in 1of the 2 cases with radiation-induced skin cancer (3 squamous cell carcinoma lesions), the novel mutations c.224delC and c.470delT were found at dipyrimidine sites of TP53 . Thus, the mutation spectrum found in tar pitch dermatopathy did not include G>T transversions arising from benzo(a)pyrene, as expected, but instead included the mutation c.625A>T, which is prevalent among tobacco-related cancers according to the IARC database. Conclusions: Skin malignancy developing under peculiar conditions provides an opportunity to investigate the human reality of environmental carcinogenesis. Although a small piece of data this information will be helpful for understanding human skin carcinogenesis in terms of occupational exposure to environmental substances and informative in precision medicine especially in precision prevention.
引用
收藏
页数:7
相关论文
共 50 条
  • [31] Methylation profiling with a panel of cancer related genes: Association with estrogen receptor, TP53 mutation status and expression subtypes in sporadic breast cancer
    Ronneberg, Jo Anders
    Fleischer, Thomas
    Solvang, Hiroko Kato
    Nordgard, Silje H.
    Edvardsen, Hege
    Potapenko, Ivan
    Nebdal, Daniel
    Daviaud, Christian
    Gut, Ivo
    Bukholm, Ida
    Naume, Bjorn
    Borresen-Dale, Anne-Lise
    Tost, Joerg
    Kristensen, Vessela
    MOLECULAR ONCOLOGY, 2011, 5 (01) : 61 - 76
  • [32] Integrative Analysis Reveals a Nine TP53 Pathway-Related lncRNA Prognostic Signature in Endometrial Cancer
    Wang, Ying
    Qu, Xiaoling
    Li, Lisha
    He, Deng
    BIOMED RESEARCH INTERNATIONAL, 2022, 2022
  • [33] Identification of a Novel TP53 Cancer Susceptibility Mutation Through Whole-Genome Sequencing of a Patient With Therapy-Related AML
    Link, Daniel C.
    Schuettpelz, Laura G.
    Shen, Dong
    Wang, Jinling
    Walter, Matthew J.
    Kulkarni, Shashikant
    Payton, Jacqueline E.
    Ivanovich, Jennifer
    Goodfellow, Paul J.
    Le Beau, Michelle
    Koboldt, Daniel C.
    Dooling, David J.
    Fulton, Robert S.
    Bender, R. Hugh F.
    Fulton, Lucinda L.
    Delehaunty, Kimberly D.
    Fronick, Catrina C.
    Appelbaum, Elizabeth L.
    Schmidt, Heather
    Abbott, Rachel
    O'Laughlin, Michelle
    Chen, Ken
    McLellan, Michael D.
    Varghese, Nobish
    Nagarajan, Rakesh
    Heath, Sharon
    Graubert, Timothy A.
    Ding, Li
    Ley, Timothy J.
    Zambetti, Gerard P.
    Wilson, Richard K.
    Mardis, Elaine R.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2011, 305 (15): : 1568 - 1576
  • [34] TP53 mutation and MET amplification in circulating tumor DNA analysis predict disease progression in patients with advanced gastric cancer
    Li, Jia
    Li, Zhaoyan
    Ding, Yajie
    Xu, Yan
    Zhu, Xiaohong
    Cao, Nida
    Huang, Chen
    Qin, Mengmeng
    Liu, Feng
    Zhao, Aiguang
    PEERJ, 2021, 9
  • [35] Multi-tiered genomic analysis of head and neck cancer ties TP53 mutation to 3p loss
    Andrew M Gross
    Ryan K Orosco
    John P Shen
    Ann Marie Egloff
    Hannah Carter
    Matan Hofree
    Michel Choueiri
    Charles S Coffey
    Scott M Lippman
    D Neil Hayes
    Ezra E Cohen
    Jennifer R Grandis
    Quyen T Nguyen
    Trey Ideker
    Nature Genetics, 2014, 46 : 939 - 943
  • [36] Multi-tiered genomic analysis of head and neck cancer ties TP53 mutation to 3p loss
    Gross, Andrew M.
    Orosco, Ryan K.
    Shen, John P.
    Egloff, Ann Marie
    Carter, Hannah
    Hofree, Matan
    Choueiri, Michel
    Coffey, Charles S.
    Lippman, Scott M.
    Hayes, D. Neil
    Cohen, Ezra E.
    Grandis, Jennifer R.
    Nguyen, Quyen T.
    Ideker, Trey
    NATURE GENETICS, 2014, 46 (09) : 939 - +
  • [37] TP53 mutation and prediction of platinum response in BRCA-mutated ovarian cancer: A prospective case-series analysis
    Lai, Eleonora
    Neri, Manuela
    Sanna, Elisabetta
    Nemolato, Sonia
    Bardanzellu, Fabio
    Scartozzi, Mario
    Giglio, Sabrina
    Maccio, Antonio
    Madeddu, Clelia
    MOLECULAR CANCER THERAPEUTICS, 2024, 23 (06)
  • [38] PARP-1 inhibition with or without ionizing radiation confers reactive oxygen species-mediated cytotoxicity preferentially to cancer cells with mutant TP53
    Liu, Qi
    Gheorghiu, Liliana
    Drumm, Michael
    Clayman, Rebecca
    Eidelman, Alec
    Wszolek, Matthew F.
    Olumi, Aria
    Feldman, Adam
    Wang, Meng
    Marcar, Lynnette
    Citrin, Deborah E.
    Wu, Chin-Lee
    Benes, Cyril H.
    Efstathiou, Jason A.
    Willers, Henning
    ONCOGENE, 2018, 37 (21) : 2793 - 2805
  • [39] Comparison of neuroendocrine differentiation and KRAS/NRAS/BRAF/PIK3CA/TP53 mutation status in primary and metastatic colorectal cancer
    Kleist, Britta
    Kempa, Marcel
    Novy, Michael
    Oberkanins, Christian
    Xu, Li
    Li, Guojun
    Loland, Christiane
    Poetsch, Micaela
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2014, 7 (09): : 5927 - U1969
  • [40] Analysis of Intrinsic Breast Cancer Subtypes: The Clinical Utility of Epigenetic Biomarkers and TP53 Mutation Status in Triple-Negative Cases
    Sadzeviciene, Ieva
    Snipaitiene, Kristina
    Scesnaite-Jerdiakova, Asta
    Daniunaite, Kristina
    Sabaliauskaite, Rasa
    Laurinaviciene, Aida
    Drobniene, Monika
    Ostapenko, Valerijus
    Jarmalaite, Sonata
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (23)